Abstract:Extracellular matrix (ECM) stiffening is a typical characteristic of cartilage aging, which is a quintessential feature of knee osteoarthritis (KOA). However, little is known about how ECM stiffening affects chondrocytes and other molecules downstream. This study mimicked the physiological and pathological stiffness of human cartilage using polydimethylsiloxane (PDMS) substrates. It demonstrated that epigenetic Parkin regulation by histone deacetylase 3 ( HDAC3 ) represents a new mechanosensitive mechanism by which the stiffness matrix affected chondrocyte physiology. We found that ECM stiffening accelerated cultured chondrocyte senescence in vitro, while the stiffness ECM downregulated HDAC3, prompting Parkin acetylation to activate excessive mitophagy and accelerating chondrocyte senescence and osteoarthritis (OA) in mice. Contrarily, intra-articular injection with an HDAC3-expressing adeno-associated virus restored the young phenotype of the aged chondrocytes stimulated by ECM stiffening and alleviated OA in mice. The findings indicated that changes in the mechanical ECM properties initiated pathogenic mechanotransduction signals, promoted the Parkin acetylation and hyperactivated mitophagy, and damaged chondrocyte health. These results may provide new insights into chondrocyte regulation by the mechanical properties of ECM, suggesting that the modification of the physical ECM properties may be a potential OA treatment strategy.

What problem does this paper attempt to address?

The problem this paper attempts to address is how extracellular matrix (ECM) stiffening affects the aging of chondrocytes and its role in the development of knee osteoarthritis (KOA). Specifically, the researchers simulated the physiological and pathological stiffness of human cartilage using polydimethylsiloxane (PDMS) substrates to reveal the critical role of histone deacetylase 3 (HDAC3) in chondrocyte response to matrix stiffness. The study found that ECM stiffening accelerated the aging of chondrocytes cultured in vitro and promoted the acetylation of Parkin by downregulating HDAC3, leading to excessive mitophagy, which in turn accelerated chondrocyte aging and the development of osteoarthritis. Additionally, the study explored whether restoring HDAC3 expression or inhibiting the PINK1/Parkin signaling pathway could serve as new strategies for treating osteoarthritis. In short, this study aims to elucidate how ECM stiffening promotes chondrocyte aging and osteoarthritis development by affecting HDAC3 levels and the autophagy process, and to explore possible interventions. This provides new insights into the pathogenesis of osteoarthritis and may open new avenues for future therapeutic strategies.

Matrix stiffening promotes chondrocyte senescence and the osteoarthritis development through downregulating HDAC3